Clinical Trials Logo

Agitation clinical trials

View clinical trials related to Agitation.

Filter by:
  • Terminated  
  • Page 1

NCT ID: NCT05665088 Terminated - Dementia Clinical Trials

Dexmedetomidine in the Treatment of Agitation Associated With Dementia (TRANQUILITY III)

Start date: December 14, 2022
Phase: Phase 3
Study type: Interventional

A study to determine the safety and efficacy of BXCL501 dosing for episodes of agitation associated with dementia when they occur (given as needed [PRN]), for a maximum of 168 doses within a 12-week treatment period.

NCT ID: NCT05276830 Terminated - Dementia Clinical Trials

An Efficacy, and Safety Study Of BXCL501 For The Treatment Of Agitation Associated With Dementia

Start date: February 8, 2022
Phase: Phase 2
Study type: Interventional

A randomized, double-blind, placebo-controlled parallel group 3-arm study assessing efficacy, safety, and tolerability of two doses BXCL501 in male and female geriatric residents (65 years and older) with acute agitation associated with all forms of dementia (i.e., probably Alzheimer's Disease, vascular dementia; mixed; frontotemporal dementia) excluding Parkinson's-Related Dementia and Lewy Body Dementia.

NCT ID: NCT03044249 Terminated - Dementia Clinical Trials

A Study of MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

Start date: May 4, 2017
Phase: Phase 2
Study type: Interventional

A ten-week study to assess MP-101 in Dementia-Related Psychosis and/or Agitation and Aggression

NCT ID: NCT02846740 Terminated - Depression Clinical Trials

Cranial Electric Stimulation to Modify Suicide Risk Factors in Psychiatric Inpatients.

Start date: March 1, 2017
Phase: N/A
Study type: Interventional

This pilot study aims to investigate whether a treatment called cranial electric stimulation or CES can decrease risk factors for suicide. The specific CES device we will use is called Alpha-Stim®. CES will be used in addition to usual treatment (medication and group therapy).

NCT ID: NCT00833300 Terminated - Delirium Clinical Trials

Haloperidol vs Olanzapine for the Management of ICU Delirium

Start date: June 2008
Phase: N/A
Study type: Interventional

The purpose of this randomized clinical trial is to determine whether haloperidol is superior to olanzapine for the treatment of ICU acquired delirium. The hypothesis is that haloperidol is in fact superior to olanzapine in treating ICU acquired delirium and sustaining delirium free time.

NCT ID: NCT00315900 Terminated - Dementia Clinical Trials

Depakote Extended Release (ER) Versus Seroquel for Agitated Behaviors in Nursing Home Care Unit Patients With Dementia

Start date: May 1, 2006
Phase: Phase 3
Study type: Interventional

The primary objective of the study is to assess the relative efficacy of Depakote ER and Seroquel for agitated behaviors among veterans with a dementia diagnosis residing in a Department of Veterans Affairs (VA) nursing home care unit (NHCU). The secondary objective of the study is to assess the relative tolerability of Depakote ER and Seroquel in this population. The primary hypothesis is that agitated dementia patients will demonstrate a significantly greater reduction in Cohen-Mansfield Agitation Inventory (CMAI) scores while treated with Depakote ER compared to treatment with Seroquel.